Art. 76 Directive (EU) 2001/83

In forcesince 21 Jul 2011cited 17×
1.

Without prejudice to Article 6, Member States shall take all appropriate action to ensure that only medicinal products in respect of which a marketing authorization has been granted in accordance with Community law are distributed on their territory.

2.

In the case of wholesale distribution and storage, medicinal products shall be covered by a marketing authorisation granted pursuant to Regulation (EC) No 726/2004 or by the competent authorities of a Member State in accordance with this Directive.

3.

Any distributor, not being the marketing authorisation holder, who imports a medicinal product from another Member State shall notify the marketing authorisation holder and the competent authority in the Member State to which the medicinal product will be imported of his intention to import that product. In the case of medicinal products which have not been granted an authorisation pursuant to Regulation (EC) No 726/2004, the notification to the competent authority shall be without prejudice to additional procedures provided for in the legislation of that Member State and to fees payable to the competent authority for examining the notification.

4.

In the case of medicinal products which have been granted an authorisation pursuant to Regulation (EC) No 726/2004, the distributor shall submit the notification in accordance with paragraph 3 of this Article to the marketing authorisation holder and the Agency. A fee shall be payable to the Agency for checking that the conditions laid down in Union legislation on medicinal products and in the marketing authorisations are observed.

The 10 that are cited most themselves, of 17.

  • Directive (EU) 2011/62Lawamends

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber), 28 June 2012. Fabio Caronna.Decision

    This reference for a preliminary ruling concerns the interpretation of Articles 76 to 84 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for …

    28 Jun 2012 · 62011CJ0007

  • Opinion of Advocate General Bot delivered on 12 June 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egéDecision

    The rules governing the wholesale distribution of medicinal products are set out in Title VII of that directive, entitled ‘Wholesale distribution and brokering of medicinal products’, which comprises Articles 76 to 85.

    12 Jun 2019 · 62018CC0222

  • Judgment of the Court (Fifth Chamber) of 18 September 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egDecision

    Title VII of Directive 2001/83, which comprises Articles 76 to 85b, covers wholesale distribution and brokering of medicinal products. Article 77 of that directive provides: ‘1. Member States shall take all appropriate measures to ensure …

    18 Sep 2019 · 62018CJ0222

  • The Medicines (Advisory Bodies) Regulations 2005Law

    … under the Act include those licences which constitute UK manufacturing and wholesale distribution authorisations under Articles 40 and 76 of Directive 2001/83/EC. Schedule 1 also makes a number of consequential amendments. Regulation 9 and …

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    (1) Nach Art. 76 Abs. 3 der Richtlinie 2001/83/EG zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel teilt jeder Großhändler, der nicht Inhaber der Genehmigung für das Inverkehrbringen ist und ein Arzneimittel aus einem …

    30 Mar 2017 · KORE318682017

  • 6B_444/2010, Urteil vom 16. September 2010 – Widerhandlung gegen das Bundesgesetz über Arzneimittel und Medizinprodukte (Heilmittelgesetz); Decision

    … 812.212.1) auf die Regeln der "guten Vertriebspraxis" (Anhang 2 lit. a und b AMBV). Diese Normen verwiesen weiter auf Art. 76 bis Art. 84 der Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates vom 6. November 2001 sowie die …

    16 Sep 2010 · 2010-09-16-6B_444-2010

  • Opinion of Advocate General Szpunar delivered on 9 January 2019. Viridis Pharmaceutical Ltd v European Union Intellectual Property Office.Decision

    The core instruments of the system of EU rules governing the medicines for human use sector are Directive 2001/83/EC [Directive of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal …

    9 Jan 2019 · 62017CC0668

  • Parket bij de Hoge Raad, 20-09-2022, 21/00270Decision

    … Hiermee wordt uitvoering gegeven aan art. 76 lid 1 Richtlijn 2001/83/EG tot vaststelling van een communautair wetboek betreffende geneesmiddelen voor menselijk gebruik, dat de lidstaten verplicht de nodige maatregelen te nemen opdat op hun …

    20 Sep 2022 · ECLI:NL:PHR:2022:832